Enova International, Inc.

ENVA

Enova International, Inc., a technology and analytics company, provides online financial services in the United States, Brazil, and internationally. The company offers consumer and small business installment loans; consumer and small business line of credit accounts; CSO programs, including arranging loans with independent third-party lenders and assisting in the preparation of loan applications and loan documents; and bank programs, such as marketing services and loan servicing for near-prime unsecured consumer installment loan. It also provides money transfer services.

About the company

Country: United StatesPrice: $169.85Market Cap: $4.2B

Investment snapshot

31%positive consensus

Scored 1d ago

Positive

BUY / PASS

Neutral / negative

6 / 5

NEUTRAL / FAIL

Median fair value

$211.63

+24.6% vs price

Models with upside

5 / 16

Positive margin of safety

Strongest signal

All 10 investors pass ENVA's cash flow

Key risk

All 4 investors flag ENVA's debt & leverage

Framework analysis

Verdict	Meaning
BUY	Positive purchase signal: the framework's buy requirements are met.
PASS	The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRAL	Neither a positive nor negative conclusion. It does not mean to hold an existing position.
FAIL	The company does not clear the framework's requirements.
Ranked	Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

Metric	Graham Defensive Value	Buffett Quality Compounder	Lynch GARP	Piotroski F-Score	Dreman Contrarian Value	Munger Quality Focus	Pabrai Dhandho Framework	Akre Three-Legged Stool	Marks Risk-Aware Value	Ackman Activist Value	Templeton Global Bargain Hunter	Sleep Scale Economies Shared	Asness Systematic Factors	Neff Low-P/E Total Return	Schloss Asset-Value Discipline	O'Shaughnessy Systematic Factor Composite
Verdict	FAIL	PASS	FAIL	NEUTRAL	NEUTRAL	BUY	NEUTRAL	NEUTRAL	NEUTRAL	BUY	FAIL	BUY	BUY	FAIL	FAIL	NEUTRAL
Score
Analysis	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…
Intrinsic Value (annual)			N/A	N/A								N/A	N/A	N/A	N/A	N/A
Margin of Safety	-43.5%	+44.9%	N/A	N/A	-39.0%	+90.1%	+19.7%	+35.0%	-109.5%	+93.4%	-117.1%	N/A	N/A	N/A	N/A	N/A
Financial Basis	TTM ended 2026-09-30 · Annual history · FY 2025 Latest source filing: 2026-10-22 Score computed: 2026-11-14	Annual history · FY 2025 Latest source filing: 2026-02-20 Score computed: 2026-11-14	Annual history · FY 2025 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30 Latest source filing: 2026-10-22 Score computed: 2026-11-14	Annual history · FY 2025 Latest source filing: 2026-02-20 Score computed: 2026-11-14	Annual history · FY 2025 · TTM ended 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-10-22 Score computed: 2026-11-14	Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 Latest source filing: 2026-10-22 Score computed: 2026-11-14	Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-02-20 Score computed: 2026-11-14	Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 Latest source filing: 2026-10-22 Score computed: 2026-11-14	Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-20 Score computed: 2026-11-14	Annual history · FY 2025 · TTM ended 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-10-22 Score computed: 2026-11-14	Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30 Latest source filing: 2026-10-22 Score computed: 2026-11-14	Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-20 Score computed: 2026-11-14	TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-10-22 Score computed: 2026-11-14	Annual history · FY 2025 · TTM ended 2026-09-30 Latest source filing: 2026-10-22 Score computed: 2026-11-14	Annual history · FY 2025 · Balance sheet at 2026-09-30 Latest source filing: 2026-10-22 Score computed: 2026-11-14	TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-10-22 Score computed: 2026-11-14

Where It Passes

Cash Flow100% pass✓ 12▾
All 10 investors pass ENVA's cash flow
Free Cash Flow Proxy$308.4M
✓BuffettPositive and growing
FCF Positive and Growing$2.0B
✓LynchPositive and growing
Operating Cash Flow$1.8B
✓PiotroskiCFO > 0
(CFO / Total Assets) vs ROACFO/Assets=28.12%, ROA=4.77%
✓PiotroskiCFO/Assets > ROA
Price / (CFO / Shares)2.3x
✓Dreman< 8x
P/E or FCF YieldP/E=14.7x, FCF Yield=42.7%
✓PabraiP/E < 15 or FCF Yield > 10%
FCF Positive14/14 years FCF positive
✓MarksPositive FCF in majority of recent years
(OCF - CapEx) / Market Cap47.8%
✓Ackman>= 4%
Price / FCF per Share2.4x
✓Ackman<= 25
Positive Operating Cash Flow frequency14/14 years positive
✓SleepPositive OCF in >= 70% of available years
Operating Cash Flow - Capital Expenditures$2.0B
✓Neff> $0 (app proxy for a strong fundamental case)
(Operating cash flow - capex) / market capitalization+48.29%; #105/4519 (top 2.3%)
✓OshaughnessyTop 10% of eligible cross-section
Efficiency67% pass✓ 2✗ 1▾
2 of 3 pass — Piotroski objects
Revenue / Total Assets Change YoY0.50x -> 0.49x
✗PiotroskiImproved YoY
Reinvestment Rate x ROIC23.1% (RR=100% x ROIC=23.1%)
✓AkreReinvestment Rate * ROIC > 10%
ROE (5-year)5/5 years above 12% (latest 23.1%)
✓SleepROE > 12% in a majority of years
Valuation models56% pass✓ 5✗ 4▾
Models split on ENVA at $169.85 — fair values range $78.24–$2568.42
Graham fair value$118.40
✗Graham-43.5% margin vs $169.85
Buffett fair value$308.37
✓Buffett+44.9% margin vs $169.85
Dreman fair value$122.20
✗Dreman-39.0% margin vs $169.85
Munger fair value$1710.13
✓Munger+90.1% margin vs $169.85
Pabrai fair value$211.63
✓Pabrai+19.7% margin vs $169.85
Akre fair value$261.34
✓Akre+35.0% margin vs $169.85
Marks fair value$81.09
✗Marks-109.5% margin vs $169.85
Ackman fair value$2568.42
✓Ackman+93.4% margin vs $169.85
Templeton fair value$78.24
✗Templeton-117.1% margin vs $169.85

Where It Falls Short

Debt & Leverage0% pass✗ 5▾
All 4 investors flag ENVA's debt & leverage
LT Debt / Total Assets Change67.67% -> 69.54%
✗PiotroskiDecreased YoY
Total Debt / Shareholders' Equity3.43
✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
Negative debt-to-equity (higher means less debt)-3.4278; #3976/4210 (top 94.4%)
✗AsnessTop 30% of eligible cross-section
Current Assets / Current Liabilities
✗SchlossCurrent ratio >= 1.50x (app cutoff)
Valuation25% pass✓ 9✗ 17▾
9 of 12 flag ENVA's valuation — Graham, Lynch, Dreman +6 more
Net income / market capitalization+9.21%; #762/6340 (top 12.0%)
✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
Price / 3-yr avg EPS20.8x
✗Graham<= 15x
Price-to-Tangible-Book Ratio4.0x
✗Graham<= 1.5x
P/E x P/TBV83.10
✗Graham<= 22.5
Basic earnings-growth PEG (dividends excluded)P/E 14.7x (growth N/A)
✗Lynch< 1.0 (ideally < 0.5)
Price / EPS14.7x
✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
Price / (CFO / Shares)2.3x
✓Dreman< 8x
Price / Tangible Book Value per Share4.0x
✗Dreman< 1.2x✗SchlossP/TBV <= 1.00x (app cutoff)
Valuation ReasonablenessP/E=14.7x, OE Yield=7.2%
✓MungerP/E < 25 or Owner Earnings Yield > 5%
P/E or FCF YieldP/E=14.7x, FCF Yield=42.7%
✓PabraiP/E < 15 or FCF Yield > 10%
P/B or P/E vs. Historical AverageP/E=14.7x, P/B=3.1x
✓MarksP/E < 15 or P/B < 2.0
Discount to Intrinsic Value-39.0% (IV=$122.20 vs Price=$169.85)
✗Marks>= 20% below intrinsic value
Price / FCF per Share2.4x
✓Ackman<= 25
Price vs. Trailing Low185% of trailing low ($91.79)
✗Templeton<= 120% of trailing low (certified split-adjusted live window)
Price / Book Value per Share3.1x
✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
Positive book equity / market capitalization+0.3776; #3363/6449 (top 52.1%)
✗AsnessTop 30% of eligible cross-section
Price / Diluted EPS14.7x
✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
(EPS CAGR % + Dividend Yield %) / P/E
✗Neff> 0.7 (Neff's published traditional edge)
Book Value per Share Change+110.8%
✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
Revenue / market capitalization+0.8792; #1923/5247 (top 36.6%)
✗OshaughnessyTop 10% of eligible cross-section
(Operating cash flow - capex) / market capitalization+48.29%; #105/4519 (top 2.3%)
✓OshaughnessyTop 10% of eligible cross-section
Trailing six-month price return through the evaluation date+17.18%; #1491/6202 (top 24.0%)
✗OshaughnessyTop 10% of eligible cross-section
Profitability44% pass✓ 22✗ 13▾
9 of 16 flag ENVA's profitability — Graham, Buffett, Lynch +6 more
Return on Equity24.4%
✓Munger> 15%✗AkreROE > 20% (3-year avg)
Net income / market capitalization+9.21%; #762/6340 (top 12.0%)
✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
Positive EPS (10 years)14/15 years positive
✗GrahamPositive EPS every year for 10 years
EPS Growth (3-yr avg, 10-yr window)293.6%
✓Graham>= 33% growth
Net Income Positive (10+ years)14/15 years positive
✗BuffettPositive every year for 10+ years
ROE (up to 5-year arithmetic mean)19.1%
✓Buffett> 15% arithmetic mean (app rule)
Operating Margin (10-yr trend)23.5% (latest)
✓BuffettStable or rising over 10 years
Free Cash Flow Proxy$308.4M
✓BuffettPositive and growing
Earnings Variance (10-yr CoV)0.81
✗BuffettCoV < 0.3
Retained Earnings Effectiveness
✗Buffett$1 retained -> > $1 market value created
Basic earnings-growth PEG (dividends excluded)P/E 14.7x (growth N/A)
✗Lynch< 1.0 (ideally < 0.5)
3-5 Year EPS CAGR-0.3%
✗Lynch15-30% (Fast Grower); > 0% to pass
ROE24.4%
✓Lynch> 15%
Net Income / Total Assets4.77%
✓PiotroskiROA > 0
ROA Change YoY3.98% -> 4.77% (delta: +0.79%)
✓PiotroskiCurrent ROA > Prior ROA
(CFO / Total Assets) vs ROACFO/Assets=28.12%, ROA=4.77%
✓PiotroskiCFO/Assets > ROA
Pre-Tax Income / Revenue13.5%
✓Dreman>= 8%
Net Income / Shareholders' Equity24.4%
✓Dreman> 12%
Margin of SafetyP/E=14.7x, P/TBV=4.0x
✓PabraiP/TBV < 1.5 or P/E < 15
ROE (high and growing)FY2023: ROE=14.1%; FY2024: ROE=17.5%; FY2025: ROE=23.1%
✗AkreLatest 3 consecutive FYs: ROE > 15% in each
Discount to Intrinsic Value-39.0% (IV=$122.20 vs Price=$169.85)
✗Marks>= 20% below intrinsic value
Positive Net Income Frequency14/14 years positive
✓MarksPositive net income in >= 7 of last 10 years
Operating Income / Revenue24.0%
✓Ackman>= 15%
Net Income / Shareholders Equity24.4%
✓Ackman>= 15%
5-Year EPS CAGR-0.3% CAGR over 5 years
✗Templeton> 0% (5-year EPS CAGR)
Operating Margin Trend19.9% (2023) -> 23.5% (2025)
✓TempletonNon-negative operating-margin trend over 3 years
Revenue growth vs. gross and operating margin trendgross margin 58.1% -> 58.1%, operating margin 19.9% -> 23.5%
✓SleepRevenue rising; gross margin flat or falling; operating margin holding
ROE (5-year)5/5 years above 12% (latest 23.1%)
✓SleepROE > 12% in a majority of years
Gross profit / total assets+28.76%; #1505/3702 (top 40.7%)
✗AsnessTop 30% of eligible cross-section
Net income / positive book equity+24.38%; #621/5226 (top 11.9%)
✓AsnessTop 30% of eligible cross-section
Negative 5-year standard deviation of ROA-0.0200; #1436/5884 (top 24.4%)
✓AsnessTop 30% of eligible cross-section
3-5 Year Diluted EPS CAGR-0.3% over 5 years
✗Neff7%-20% annualized
Positive Diluted-EPS Years10/10 years positive
✓Schloss>= 70% positive over 5-10 observed years (app rule)
Growth50% pass✓ 7✗ 5▾
4 of 8 pass — Lynch, Ackman, Templeton +1 more object
EPS Growth (3-yr avg, 10-yr window)293.6%
✓Graham>= 33% growth
Basic earnings-growth PEG (dividends excluded)P/E 14.7x (growth N/A)
✗Lynch< 1.0 (ideally < 0.5)
3-5 Year EPS CAGR-0.3%
✗Lynch15-30% (Fast Grower); > 0% to pass
EPS Growth Direction$1.78 (2012) -> $11.52 (2025)
✓DremanPositive over recent years
EPS CAGR15.4% CAGR over 13 years
✓Dreman> 5% annualized
Positive Net Income Frequency14/14 years positive
✓MarksPositive net income in >= 7 of last 10 years
3yr Median Revenue Growth22.0%
✓Ackman>= 5%
Positive EPS Growth Frequency2/5 years with positive EPS growth
✗AckmanPositive EPS growth in >= 3 of last 5 years
5-Year EPS CAGR-0.3% CAGR over 5 years
✗Templeton> 0% (5-year EPS CAGR)
Revenue growth vs. gross and operating margin trendgross margin 58.1% -> 58.1%, operating margin 19.9% -> 23.5%
✓SleepRevenue rising; gross margin flat or falling; operating margin holding
5-year Revenue CAGR23.8%
✓SleepCAGR > 7%
3-5 Year Diluted EPS CAGR-0.3% over 5 years
✗Neff7%-20% annualized
Verdicts50% pass✓ 5✗ 5▾
Split decision: 6 NEUTRAL · 5 FAIL · 4 BUY · 1 PASS
Overall verdict
✗GrahamFAIL (2/7)✓BuffettPASS (3/6)✗LynchFAIL (2/4)•PiotroskiNEUTRAL (F-Score 5)•DremanNEUTRAL (6/9)✓MungerBUY (3/3)•PabraiNEUTRAL (2/3)•AkreNEUTRAL (3/5)•MarksNEUTRAL (3/4)✓AckmanBUY (7/8)✗TempletonFAIL (2/8)✓SleepBUY (6/6)✓AsnessBUY (Rank #271/2370 (Top 11.4%))✗NeffFAIL (3/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked)

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Banking

SIC Sector: Credit Institutions

Size: Mid Cap($4.2B)

Revenue: $3.2B+18.6% YoY

Net Income: $308.4M+47.2% YoY

Financial Snapshot

Operating Margin23.5%

Return on Equity23.1%

Debt / Equity3.37

Current Ratio--

EPS (Diluted)$11.52+55.0% 1y

Buybacks (1y)$214.6M

Buybacks (2y)$503.9M

Shares Retired4.2% / 15.0% 2y

Similar Companies

MUFGMITSUBISHI UFJ FINANCIAL GROUP INC

$245.7B

AXPAMERICAN EXPRESS CO

$215.0B

SANBanco Santander, S.A.

$175.9B

ATMPBARCLAYS BANK PLC

$82.1B

Sector-adjusted criteria: Bank

Leverage is a bank’s business model and current accounts don’t exist on its balance sheet, so debt and liquidity tests are omitted and tangible book value and ROE replace their industrial analogs.

Shareholder Return

Fiscal 2025

Retired 4.2% of shares last year, 15.0% over two.

Buybacks: $214.6M
Dividends: —

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY22

−8.8% = −19.1% + 12.6%

FY23

−11.3% = −15.6% + 5.1%

FY24

35.3% = 19.6% + 13.2%

FY25

55.0% = 47.2% + 5.3%

Earnings Fewer shares More shares

The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

Metric	TTM · 2026-09-30 2025-10-01 – 2026-09-30 Sources · derived quarter values 10-K · 2026-02-20 10-Q · 2026-04-23 10-Q · 2026-07-23 10-Q · 2026-10-22 Derived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, interest expense, operating cash flow, depreciation amortization, capex, buybacks.	Q3 FY 2026 2026-07-01 – 2026-09-30 Sources · derived quarter values 10-Q · 2026-10-22 Derived from cumulative filings: operating cash flow, capex, buybacks.	Q2 FY 2026 2026-04-01 – 2026-06-30 Sources · derived quarter values 10-Q · 2026-07-23 Derived from cumulative filings: operating cash flow, capex, buybacks.	Q1 FY 2026 2026-01-01 – 2026-03-31 Sources 10-Q · 2026-04-23	FY 2025 Sources 10-K · 2026-02-20	FY 2024 Sources 10-K · 2025-02-18	FY 2023 Sources 10-K · 2024-02-23	FY 2022 Sources 10-K · 2023-02-24	FY 2021 Sources 10-K · 2022-02-28
Market Cap	$4.2Bcurrent	--	--	--	$4.1Best.	$2.9Best.	$1.6Best.	$1.4Best.	$1.4Best.
Revenue	$3.7B↑20%	$1.0B↑26%	$928.9M↑22%	$875.1M↑17%	$3.2B↑19%	$2.7B↑26%	$2.1B↑22%	$1.7B↑44%	$1.2B
Operating Income	$878.1M↑24%	$247.2M↑26%	$237.1M↑29%	$207.1M↑20%	$739.4M↑26%	$584.8M↑39%	$422.1M↑10%	$384.0M↓7%	$413.1M
Net Income	$382.4M↑30%	$107.3M↑34%	$105.1M↑38%	$91.1M↑25%	$308.4M↑47%	$209.4M↑20%	$175.1M↓16%	$207.4M↓19%	$256.3M
EPS (Diluted)	--	$4.06↑34%	$4.00↑40%	$3.46↑29%	$11.52↑55%	$7.43↑35%	$5.49↓11%	$6.19↓9%	$6.79
Gross Margin	60.6%↑6%	60.9%↑6%	61.2%↑6%	60.4%↑6%	58.1%↑1%	57.5%↓1%	58.1%↓10%	64.4%↓24%	84.8%
Operating Margin	24.0%↑3%	24.5%	25.5%↑6%	23.7%↑3%	23.5%↑7%	22.0%↑10%	19.9%↓10%	22.1%↓35%	34.2%
ROE	24.4%↑7%	—	—	—	23.1%↑32%	17.5%↑24%	14.1%↓19%	17.5%↓25%	23.4%
Total Debt	$5.4B↑31%	$5.4B↑31%	$5.0B↑27%	$4.8B↑29%	$4.5B↑26%	$3.6B↑21%	$2.9B↑30%	$2.3B↑63%	$1.4B
Shareholders' Equity	$1.6B↑22%	$1.6B↑22%	$1.5B↑22%	$1.4B↑17%	$1.3B↑12%	$1.2B↓3%	$1.2B↑5%	$1.2B↑9%	$1.1B
Current Ratio	—	—	—	—	—	—	—	—	—
Debt / Equity	3.43↑7%	3.43↑7%	3.35↑4%	3.45↑10%	3.37↑13%	2.98↑25%	2.37↑25%	1.90↑50%	1.27
Operating Cash Flow	$2.1B↑17%	$535.6M↑11%	$544.0M↑22%	$474.5M↑21%	$1.8B↑18%	$1.5B↑32%	$1.2B↑31%	$894.0M↑89%	$471.9M
Free Cash Flow	$2.0B↑18%	$524.0M↑11%	$531.4M↑22%	$463.8M↑23%	$1.8B↑19%	$1.5B↑33%	$1.1B↑32%	$850.4M↑92%	$442.2M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Banking

ENVA vs Peers — Financial Grading

Revenue$3.2BBottom 25%

Net Income$308.4MBottom 25%

ROE23.1%Top 25%

D/E3.37Bottom 25%

Op. Margin23.5%Median

Curr. Ratio—

Company	Market Cap	Price	Revenue	Net Income	ROE	D/E	Op. Margin	Curr. Ratio	Graham	Buffett	Lynch	Piotroski	Dreman
MITSUBISHI UFJ FINANCIAL GROUP INCMUFG	$245.7B	$21.83	$74.2B	$10.8B	8.8%	1.12	19.9%	—	2/7	1/6	1/4	F-Score 5	3/9
AMERICAN EXPRESS COAXP	$215.0B	$320.60	$41.3B	$10.8B	32.4%	1.68	—	—	2/7	3/6	3/4	F-Score 4	3/9
Banco Santander, S.A.SAN	$175.9B	$12.21	—	$16.6B	12.5%	0.02	—	—	2/7	1/6	2/4	F-Score 4	5/9
BARCLAYS BANK PLCATMP	$82.1B	$35.04	$13.1B	$6.3B	7.5%	0.01	—	—	2/7	1/6	0/4	F-Score 7	4/9
BARCLAYS PLCBCS	$76.0B	$22.87	$15.0B	$9.7B	9.2%	0.02	—	—	1/7	0/6	0/4	F-Score 7	2/9
FIRST CITIZENS BANCSHARES INC /DE/FCNCA	$25.7B	$2324.25	$9.5B	$2.2B	9.9%	1.62	—	—	5/7	3/6	1/4	F-Score 5	2/9
KEYCORP /NEW/KEY	$22.7B	$21.46	$7.5B	$1.8B	9.0%	0.49	—	—	2/7	1/6	1/4	F-Score 6	4/9
WEBSTER FINANCIAL CORPWBS	$12.6B	$77.57	$2.9B	$1.0B	10.6%	0.08	50.7%	—	2/7	1/6	1/4	F-Score 7	2/9